As 2024 is nearing its end, investors with a time machine are looking to visit December 2023 and take their long positions in ...

The Russian mRNA vaccine under development can be “personalised” based on the genetic analysis of each person’s tumour to ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Russia’s still to be verified claim of developing a cancer vaccine is one of the many in the works around the world ...

A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...

A pharmaceutical company sued a lawmaker, saying he spread unfounded claims that its COVID-19 vaccine was a “bioweapon” and ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...

Experts working on Australia's first mRNA jab believe they have solved the issue causing the declining effectiveness of ...

New Alzheimer's disease drugs, a world-first skin cancer vaccine, and personalised health apps that change the way we track ...

Korea boosts drug pricing for domestic raw materials and aims for mRNA vaccine by 2028 Korea announces strategies for enhancing drug production and improving vaccine development by 2028 ...

Middlemen get a bad rap for adding cost and complications to an operation. So, eliminating the go-betweens can reduce expense ...